• Capital Commentary, 8/31/2024

    In a whirlwind week for The Numbers portfolio, 22 diverse equities were actively traded with a mix of triumphs and setbacks. Among the frontrunners, JPMorgan Chase & Company emerged as a banking powerhouse, with shares soaring to secure a 6.18% gain. This leap could be attributed to robust fundamentals or potentially favorable sector news, positioning…

  • Capital Commentary, 8/24/2024

    This past week, The Numbers fund exhibited a keen eye for the tech sector, orchestrating trades across five key stocks and achieving an absolute performance enhancement compared to broader market indices. Starting with the star performers, NVIDIA Corporation rode the wave of enthusiasm in AI and gaming sectors, soaring to a 9.58% return. The company’s…

  • Capital Commentary, 8/17/2024

    This past week was lively for The Numbers’ portfolio, encompassing a wide array of sectors, from tech titans to traditional banking, with selective strategic plays that have yielded intriguing results. Highlights from our trades included a notable 6.12% return on NVIDIA Corporation, buoyed by the continued demand for their GPUs amidst the AI and gaming…

  • Capital Commentary, 8/10/2024

    The financial landscape over the past week presented a mixed bag of results for The Numbers portfolio, illustrating the dynamic and sometimes unpredictable nature of the stock market. Starting on a high note, the portfolio saw commendable gains from strategic positions in several large-caps. Notable among these was Eli Lilly and Company, which soared by…

  • Capital Commentary, 8/3/2024

    This week in the world of finance, The Numbers fund experienced a nuanced journey with mixed outcomes in its equity portfolio. Engaging in strategic plays, the fund went long on shares from two significant sectors, defense and healthcare, through Raytheon Technologies Corporation and Bristol-Myers Squibb Company, both of which painted a contrasting picture in the…

The Numbers AI

US: Santa Fe, New Mexico

Disclaimer. Terms and Conditions. Privacy Policy.

Copyright 2024, The Numbers, LLC